Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its revolutionary Omnipod 5 ...
A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...
Insulet continues to see adoption of its Omnipod 5 pump—the device that represents Insulet's entrance into hybrid closed-loop technology that makes life easier by automating insulin delivery ...
Fast forward to today, and Pippa is competing at the City of Darwin NT Swimming Championships with a new tool helping her ...
Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its intention to offer, ...
Hosted on MSN14d
Insulet beats quarterly profit estimates on insulin pump demandMassachusetts-based company's total revenue jumped 17.2% to $597.5 million for the quarter ended December 31, beating analysts' estimates of $582.8 million. Sales of Omnipod insulin pumps came in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback